MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1126/science.abe1107

Медицинская библиотека · Science (New York, N.Y.) · 2020

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.

Ng Kevin W, Faulkner Nikhil, Cornish Georgina H, Rosa Annachiara, Harvey Ruth, Hussain Saira, Ulferts Rachel, Earl Christopher, Wrobel Antoni G, Benton Donald J, Roustan Chloe, Bolland William, Thompson Rachael, Agua-Doce Ana, Hobson Philip, Heaney Judith, Rickman Hannah, Paraskevopoulou Stavroula, Houlihan Catherine F, Thomson Kirsty, Sanchez Emilie, Shin Gee Yen, Spyer Moira J, Joshi Dhira, O'Reilly Nicola, Walker Philip A, Kjaer Svend, Riddell Andrew, Moore Catherine, Jebson Bethany R, Wilkinson Meredyth, Marshall Lucy R, Rosser Elizabeth C, Radziszewska Anna, Peckham Hannah, Ciurtin Coziana, Wedderburn Lucy R, Beale Rupert, Swanton Charles, Gandhi Sonia, Stockinger Brigitta, McCauley John, Gamblin Steve J, McCoy Laura E, Cherepanov Peter, Nastouli Eleni, Kassiotis George

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Zoonotic introduction of novel coronaviruses may encounter preexisting immunity in humans. Using diverse assays for antibodies recognizing SARS-CoV-2 proteins, we detected preexisting humoral immunity. SARS-CoV-2 spike glycoprotein (S)-reactive antibodies were detectable using a flow cytometry-based method in SARS-CoV-2-uninfected individuals and were particularly prevalent in children and adolescents. They were predominantly of the immunoglobulin G (IgG) class and targeted the S2 subunit. By contrast, SARS-CoV-2 infection induced higher titers of SARS-CoV-2 S-reactive IgG antibodies targeting both the S1 and S2 subunits, and concomitant IgM and IgA antibodies, lasting throughout the observation period. SARS-CoV-2-uninfected donor sera exhibited specific neutralizing activity against SARS-CoV-2 and SARS-CoV-2 S pseudotypes. Distinguishing preexisting and de novo immunity will be critical for our understanding of susceptibility to and the natural course of SARS-CoV-2 infection.

Для цитирования: Ng Kevin W, Faulkner Nikhil, Cornish Georgina H, Rosa Annachiara, Harvey Ruth, Hussain Saira, Ulferts Rachel, Earl Christopher, Wrobel Antoni G, Benton Donald J, Roustan Chloe, Bolland William, Thompson Rachael, Agua-Doce Ana, Hobson Philip, Heaney Judith, Rickman Hannah, Paraskevopoulou Stavroula, Houlihan Catherine F, Thomson Kirsty, Sanchez Emilie, Shin Gee Yen, Spyer Moira J, Joshi Dhira, O'Reilly Nicola, Walker Philip A, Kjaer Svend, Riddell Andrew, Moore Catherine, Jebson Bethany R, Wilkinson Meredyth, Marshall Lucy R, Rosser Elizabeth C, Radziszewska Anna, Peckham Hannah, Ciurtin Coziana, Wedderburn Lucy R, Beale Rupert, Swanton Charles, Gandhi Sonia, Stockinger Brigitta, McCauley John, Gamblin Steve J, McCoy Laura E, Cherepanov Peter, Nastouli Eleni, Kassiotis George. Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.. Science (New York, N.Y.). 2020. DOI: 10.1126/science.abe1107.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.